Tokyo, Sept 2, 2009 (JCN) - Kuraray Medical, a subsidiary of Kuraray, has obtained approval under the Pharmaceutical Affairs Law to manufacture and market its artificial bone graft medical devices. A artificial bone graft is a product used for medical treatment should a bone transplant become necessary as a result of disease or injury.
The three types of bone transplants are an autologous bone graft whereby a portion of a bone is taken from and transplanted within the same body, those from donor individuals to separate recipients, and those involving a supplemental element made using a artificial bone graft.
At present, autologous bone grafts are the predominant type of bone transplant in Japan. However, this requires healthy bone to be cut away from the patient's own body. Kuraray thus aimed to develop the third type, a artificial bone graft that could replace autologous bone grafts.
Kuraray Medical developed the new bone grafts in collaboration with the Ceramic Biomaterial Group, Biomaterials Center, National Institute for Materials Science and the Department of Orthopedics, Institute of Clinical Medicine, The University of Tsukuba.
Made of hydroxylapatite, the chief component of living bone, the aligned connectivity and porous structure of this product are conducive to binding together with surrounding bone and supplementing bone growth into the internal portion of the graft.
This product will be available nationwide following limited sales at selected medical facilities. Kuraray Medical is positioning this product as a cornerstone of its efforts to develop the artificial bone graft market.
Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
 |
|
Kuraray SEPTON K Elastomer Features Superior Bondability to Glass and Metal
(Oct 9, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft
(Sept 2, 2009)
|
|
|
Notice Concerning Acquisition of PVB Resin-Related Intellectual Property
(Oct 23, 2008)
|
|
|
Price of Heat-Resistant Polyamide Resin GENESTAR Revised
(Oct 2, 2008)
|
|
|
Kuraray to Raise Prices in May
(Apr 8, 2008)
|
|
|
Kuraray Forms Water Treatment System Venture
(Feb 18, 2008)
|
|
|
Kuraray Unit to Double Annual Output of Elastomer Compound
(Aug 20, 2007)
|
|
|
Kuraray Plastics Develops Turpolin Sheet with Reduced CO2
(Nov 28, 2006)
|
|
|
Tekken and Kuraray to Launch a New Construction Method for Tunnels
(Sept 20, 2006)
|
|
|
Kuraray to Expand Production of VF-PE Optical-use Poval Film for Use in LCD
(Aug 11, 2006)
|
|
|
Recent
Health/Medical
News
|
RSS
|
|
|
|
|
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
|
|
|
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
|
|
|
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
|
|
|
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
|
|
|
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)
|
More Health/Medical news...
|
|
